US Stocks
/
Supernus Pharmaceuticals, Inc. Share Price

Supernus Pharmaceuticals, Inc. Share Price

NASDAQ: SUPN | Mid Cap
$42.11
-$0.91 (-2.13%) Last updated on 09 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Supernus Pharmaceuticals, Inc. Stock Performance

Open
$42.78
Prev. Close
$43.02
Circuit Range
N/A
Day Range
$41.13 - $42.80
Year Range
$40.52 - $59.45
Volume
30,705
Average Traded
$41.92

Supernus Pharmaceuticals, Inc. Share Price Today

As of 9 October 2026, Supernus Pharmaceuticals, Inc.'s share price is $42.11. The stock opened at $42.78, compared to its previous close of $43.02. During today's trading session, Supernus Pharmaceuticals, Inc.'s share price traded between $41.13 and $42.80, with an average price of $41.97. Over the past 52 weeks, the stock has recorded a high of $59.45 and a low of $40.52. In terms of performance, Supernus Pharmaceuticals, Inc.'s share price has declined by 12.27% over the last six months and is down 23.60% on a year-on-year basis.

Supernus Pharmaceuticals, Inc. Share Price Chart

$41.13$42.80
L
Show Current Price
H

Supernus Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators

Market Cap
$2.38B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.89
Revenue (TTM)
$718.95B
Return On Equity (TTM)
-10.66%
Profit Margin
-5.36%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-29.37%

Supernus Pharmaceuticals, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$192.10$211.57$207.71$219.06
Net Profit-$45.12-$4.11-$2.29-$58.37
Net Profit Margin-23.49%-1.94%-1.10%-26.65%
Income ChangeN/A90.89%44.28%-2448.91%

Supernus Pharmaceuticals, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$667.24$607.52$661.82$718.95
Net Profit$60.71$1.32$73.87-$38.55
Net Profit Margin9.10%0.22%11.16%-5.36%
Income ChangeN/A-97.83%5496.21%-152.19%

About Supernus Pharmaceuticals, Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.

Supernus Pharmaceuticals, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$43.23
$42.27
-1.91%
Sep 2026
$44.52
$43.09
-2.48%
Aug 2026
$50.45
$44.19
-0.99%
Jul 2026
$46.95
$44.63
-4.08%
Jun 2026
$46.02
$46.53
+0.85%
May 2026
$47.81
$46.14
-3.87%
Apr 2026
$51.37
$48.00
-7.12%
Mar 2026
$54.52
$51.68
-5.64%
Feb 2026
$48.63
$54.77
+13.70%
Jan 2026
$49.27
$48.17
-3.03%
Dec 2025
$45.45
$49.67
+8.72%
Nov 2025
$55.15
$45.69
-17.11%

SUPN Share Price FAQs

What is Supernus Pharmaceuticals, Inc. share price today?

chevron-up
Supernus Pharmaceuticals, Inc. share price today is $42.11 as on October 9, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Supernus Pharmaceuticals, Inc. stock?

chevron-up
The 52 week high of Supernus Pharmaceuticals, Inc. stock is $59.45, while the 52 week low is $40.52 as of 9 Oct '26.

What is SUPN's market capitalisation today?

chevron-up
SUPN market capitalisation is $2.38B as of October 9, 2026, at 9:54 am IST.

What is SUPN's net income for the last quarter?

chevron-up
SUPN's net income for the last quarter is -58.37B USD.

What is the 5 year returns of SUPN?

chevron-up
The 5 year returns of SUPN is 41.07% as on 9 Oct '26.

What is the high & low stock price of SUPN today?

chevron-up
SUPN stock price hit a high of $42.80 and low of $41.13 as of 9 Oct '26.

Can I buy SUPN shares in India?

chevron-up
Yes. You can buy SUPN in India by opening an international trading account.